Global Proton Pump Inhibitors Industry Predicts US$4.9 Billion Growth with a 5.2% CAGR by 2033 | FMI

Future Market Insights (FMI), a leading market research firm, has unveiled its latest industry analysis, forecasting a robust expansion in the Global Proton Pump Inhibitors Industry. Anticipating a Compound Annual Growth Rate (CAGR) of 5.2%, the market is poised to surge from a valuation of US$ 2.8 Billion in 2022 to a substantial US$ 4.9 Billion by 2033.

The driving force behind this remarkable growth is the escalating prevalence of gastrointestinal disorders on a global scale. Conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Helicobacter pylori infections are becoming increasingly prevalent, underscoring the critical need for effective treatment options.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-17480

Strong research and development (R&D) activities are a key driver of the Proton Pump Inhibitor (PPI) market. Ongoing R&D efforts in the field of gastroenterology and drug development have led to the introduction of new and improved PPI formulations. These innovations, including novel drug delivery systems and enhanced efficacy profiles, attract healthcare professionals and patients alike. The continuous pursuit of advancements in PPI medications not only improves treatment options but also addresses the evolving needs of patients with gastrointestinal disorders. Consequently, the market for PPIs is propelled forward by the commitment to R&D, fostering innovation, and ultimately providing better therapeutic solutions for patients worldwide.

Top Highlights by FMI’s Analysis:

  • Omeprazole dominates the Proton Pump Inhibitors (PPIs) market, holding a significant market share of 28.5% in 2022. This leading position is driven by various factors, including its widespread availability, proven efficacy, and comparatively lower cost compared to other PPI drugs.
  • The oral route of administration holds the leading position with a market share of 66.3% in 2022. Oral administration is the preferred method for delivering Proton Pump Inhibitors due to its convenience, ease of use, and high patient acceptance. It allows for effective systemic delivery of the medication, contributing to its dominant position in the market.
  • Capsules are the leading dosage form with a market share of 39.2% in the global Proton Pump Inhibitors market in 2022. Capsules offer advantages such as easy swallowing, accurate dosing, and protection of the medication from degradation. They are preferred by healthcare professionals and patients for their convenience and effectiveness in delivering Proton Pump Inhibitors for treatment.
  • Generics held a 74.3% market value share in 2022 in the global Proton Pump Inhibitors market based on prescription type. Generic Proton Pump Inhibitors have gained prominence due to their cost-effectiveness, comparable efficacy, and availability as alternatives to brand-name medications.
  • North America leads the global market in terms of region accounting for 38.8% market share in 2022. This is attributed to factors such as the high prevalence of gastrointestinal disorders, well-established healthcare infrastructure, robust research and development activities, and strong market presence of key pharmaceutical companies.

Global Proton Pump Inhibitors Industry Competitive Landscape:

The market players active within this industry space are undertaking the launch of new products to continue maintaining their market share in the global market.

  • In April 2022, Daewon Pharmaceutical launched Escorten, its inaugural proton-pump inhibitor (PPI) treatment, utilizing 10mg of esomeprazole magnesium trihydrate, effectively addressing gastric mucosal lesions in acute and chronic gastritis in Korea.
  • On March 25, 2021, Xiromed LLC, a generic division of Insud Pharmaceuticals, launched Omeprazole delayed-release capsules, 20mg, as a cost-effective alternative to Prilosec®. CEO Narasimhan Mani expressed their commitment to expanding the product portfolio.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-17480

Major Players are:

AstraZeneca, Bayer AG, Cadila Pharmaceuticals, Eisai Inc., GlaxoSmithKline PLC, Pfizer Inc., Takeda Pharmaceuticals, Sanofi SA, Perrigo Company PLC, Dr. Reddy’s Laboratories, Redhill Pharma Limited, Cipla Limited

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Proton Pump Inhibitors market in its latest study, presenting a historical demand assessment of 2017 to 2022 and projections for 2023 to 2033. The global Proton Pump Inhibitors market is segmented in detail to cover every market aspect and present a complete market intelligence approach to the reader.

The research study is based on the Proton Pump Inhibitors market by drug type (omeprazole, pantoprazole, rabeprazole, dexlansoprazole, lansoprazole, esomeprazole, and others), by route of administration (oral, and injectable), by dosage form (tablet, capsules, injection, and others), by prescription type (branded, and generics), by indication (gastroesophageal reflux disease, heartburn, peptic ulcer, and others), by distribution channel (retail pharmacies, hospital pharmacies, drug stores, and specialty clinics), and across 7 regions of the world.

Global Proton Pump Inhibitors Industry Key Segmentation:

By Drug Type:

  • Esomeprazole
  • Omeprazole
  • Dexlansoprazole
  • Pantoprazole
  • Rabeprazole
  • Lansoprazole
  • Others

By Route of Administration:

  • Oral
  • Injectable

By Dosage Form:

  • Tablet
  • Capsules
  • Injection
  • Others

By Prescription:

  • Branded
  • Generics

By Indication:

  • Gastroesophageal Reflux Disease
  • Heartburn
  • Peptic ulcers
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Specialty Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Radiation-Induced Fibrosis Treatment Industry Soars to New Heights, Projections Show a CAGR of 6.4% and US$ 137.1 Million by 2033 | FMI

In coming years, the Global Radiation-Induced Fibrosis Treatment Industry will likely grow significantly due to several factors that will increase demand for efficient therapies. Recent market research projects that the market for radiation-induced fibrosis treatment will develop at a CAGR of 6.4% over the forecast period and reach a value of US$ 137.1 Million in 2033.

The growing incidence of cancer is a primary driving factor behind the substantial growth of the Global Radiation-Induced Fibrosis Treatment Industry. As more patients undergo radiation therapy for cancer, the incidence of radiation-induced fibrosis is also rising. This has led to increased demand for effective treatment options to manage this condition.

Likewise, the development of innovative treatments and advances in medical technology are expected to drive the growth of the radiation-induced fibrosis treatment market in the coming years. For instance, immunotherapy is becoming a popular treatment option due to its efficacy, minimal side effects, personalized approach, and long-term benefits.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-13900

Moreover, the increasing geriatric population and favorable government initiatives are expected to create significant opportunities for the growth of radiation-induced fibrosis treatment. The growing awareness among patients and healthcare providers regarding radiation-induced fibrosis, its symptoms, and treatment options is also propelling the growth of this market.

Retail pharmacy is expected to hold the major share in the radiation-induced fibrosis treatment market as a distribution channel. The convenience of retail pharmacies, their wide distribution, and efficient logistics make them a preferred distribution channel for radiation-induced fibrosis treatments.

Overall, the radiation-induced fibrosis treatment market is poised for significant growth in the coming years, thanks to the positive market trends and the potential driving factors behind it.

Key Takeaways from Global Radiation-Induced Fibrosis Treatment Industry Study

  • By drug class, Immunotherapy segment held a prominent market share of about 4% in the global market, in 2022. High preference of this segment is owed to minimal side effects of immunotherapy
  • By route of administration, oral segment held a major chunk of the market at around 2% in the global market, in 2022 as they are easier for patients to comply with and can also improve patient outcomes and overall treatment success.
  • By distribution channel, retail pharmacies held a market share of around 8% in 2022 owed to their easy accessibility by patients.
  • North America dominated the global market with U.S. contributing around US$ 20.4 Million in 2022.

“Rigorous Research and Development Efforts Undertaken by the Manufacturers to Innovate Novel Methods and Treatment Approached for the Fibrosis Treatment May Provide Significant Growth Opportunity for Radiation Induced Fibrosis Treatment Market over the forecast period,” says an analyst of Future Market Insights.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13900

Global Radiation-Induced Fibrosis Treatment Industry Competition

Key manufacturers in the Global Radiation-Induced Fibrosis Treatment Industry employ a range of strategies to gain a competitive edge and increase their market share. These strategies include developing new and innovative drugs, acquisitions and expansions, strategic collaborations, pricing strategies, and regulatory compliance.

  • In June 2021, Bayer AG announced the acquisition of Vividion Therapeutics for up to $2 billion, expanding its oncology portfolio with Vividion’s innovative small molecule drug discovery platform, including radiation-induced fibrosis treatments.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Global Radiation-Induced Fibrosis Treatment Industry in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global radiation-induced fibrosis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the radiation-induced fibrosis treatment market by drug class – (corticosteroids, anti-fibrotic drugs, immunotherapy, and immunoglobulin), route of administration – (oral, injectable, and topical), distribution channel – (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven key regions of the world.

Global Radiation-Induced Fibrosis Treatment Industry Key Companies Profiled        

  • Boehringer Ingelheim
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline plc
  • Bristol Myers Squibb Company
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Eli Lilly and Company
  • AbbVie Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Mylan N.V.
  • Bayer AG
  • Celgene Corporation (Bristol Myers Squibb)

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/13900

Key Market Segments Covered in Global Radiation-Induced Fibrosis Treatment Industry Analysis

By Drug Class:

  • Corticosteroids
  • Anti-fibrotic Drugs
  • Immunotherapy
  • Immunoglobulin

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Retinal Gene Therapy Industry Predicting a Prominent US$ 235.4 Million Value with 9.2% CAGR by 2033 | FMI

In the coming years, the Global Retinal Gene Therapy Industry is poised for substantial growth, driven by factors that underscore the rising demand for efficient therapeutic solutions. Recent in-depth market research conducted by [Your Company Name or FMI] indicates a projected Compound Annual Growth Rate (CAGR) of 9.2% over the forecast period, culminating in a remarkable market value of US$ 235.4 Million by the year 2033.

One of the prominent factors is the growing incidence rate of inherited retinal diseases globally, such as age-related macular degeneration (AMD), Stargardt disease and retinitis pigmentosa, and other inherited forms of blindness, creating a massive unaddressed patient pool that retinal gene therapy could treat. This high unmet need has given a powerful impetus to the rise of innovative gene therapies to fulfill these unmet medical needs.

Advances in technology in gene therapy research and development, have expedited the delivery and execution of retinal gene therapy. Favorable regulatory frameworks, strong governmental support, and funding towards retinal gene therapy research and development, further enhance market growth.

Expansion opportunities in new geographic regions and the potential for new therapies beyond the gene therapy space for the betterment of vision research.

The Global Retinal Gene Therapy Industry is expected to continue experiencing rapid growth with the potential to reach new milestones and provide breakthrough treatments for inherited retinal diseases and other forms of blindness.

In conclusion, the retinal gene therapy market is expected to continue on a trajectory of rapid growth with the global incidence of retinal diseases and the need for treatments driving the need for continued innovation and research in the field.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-10246

Key Takeaways from Global Retinal Gene Therapy Industry Study

  • By indication, Stargardt disease segment held a prominent market share of about 8% in the global market, in 2022 owed to its high prevalence creating high demand for retinal gene therapy.
  • By end user, hospitals held a market share of around 6% in 2022 as they provide specialization and expertise in delivering the therapy.
  • North America dominated the global market with U.S. contributing around US$ 30.8 Million in 2022.

“Technological advancements and increasing capital investment in research and development efforts by the government and private organizations to create lucrative opportunities for the Global Retinal Gene Therapy Industry throughout the forecast period,” says an analyst of Future Market Insights.

Global Retinal Gene Therapy Industry Competition

The market is characterized by a high level of market concentration, with a few key players dominating the market. However, these key players aim to promote innovation via continuous developments of new therapeutic pipelines and strategic collaborations, driving competition, and new commercial opportunities.

  • In October 2020, Novartis acquired Vedere Bio, a company that specializes in optogenetics and AAV gene therapy.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Global Retinal Gene Therapy Industry in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global retinal gene therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the by indication – (leber congenital amaurosis (LCA), Stargardt disease, choroideremia, x-linked retinitis pigmentosa (RP), and others), end user – (hospitals, academic & research institutes, ophthalmic clinics, and others), across seven key regions of the world.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-10246

Key Companies Profiled in the Global Retinal Gene Therapy Industry:     

  • Gyroscope Therapeutics (Novartis)
  • Applied Genetic Technologies Corporation (AGTC)
  • Spark Therapeutics
  • Adverum Biotechnologies
  • REGENXBIO Inc.
  • Biogen Inc.
  • Nightstar Therapeutics
  • MeiraGTx Holdings plc
  • GenSight Biologics
  • RetroSense Therapeutics
  • Second Sight Medical Products
  • Oxford Biomedica
  • Hemera Biosciences
  • Adverio Pharmaceuticals

Key Market Segments Covered in Global Retinal Gene Therapy Industry Analysis

By Indication:

  • Leber Congenital Amaurosis (LCA)
  • Stargardt Disease
  • Choroideremia
  • X-linked Retinitis Pigmentosa (RP)
  • Others

By End User:

  • Hospitals
  • Academic & Research Institutes
  • Ophthalmic Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/10246

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cardiovascular Diagnostics Industry on Track to Exceed US$9.7 Billion by 2033 with Consistent 5.1% CAGR | FMI

The Global Cardiovascular Diagnostics Industry is on a trajectory of unprecedented growth, forecasted to surge from US$ 5.6 Billion in 2022 to a staggering US$ 9.7 Billion by the conclusion of 2033. This remarkable expansion, projected at a robust Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period (2023 to 2033), underscores the burgeoning significance of cardiovascular health on a global scale.

A confluence of factors is fueling this substantial market growth, chief among them being the escalating prevalence of cardiovascular diseases (CVD) worldwide. As tobacco consumption continues to rise across the globe, the incidence of cardiovascular disorders has followed suit, necessitating advanced diagnostic solutions to combat this pervasive health challenge.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17465

By developing new imaging technologies, portable diagnostic gadgets, and molecular diagnostic techniques, manufacturers can innovate and improve patient care. Furthermore, the use of data analytics and AI algorithms improves diagnostic accuracy and clinical decision-making. However, problems such as a shortage of skilled staff, budgetary constraints, and insufficient regulations and policies are limiting market expansion.

The market experienced growth in 2021, surpassing initial projections before the COVID-19 pandemic. Since the emergence of COVID-19 three years ago, over 750 million individuals worldwide have been affected by the disease. Recent studies have indicated that certain individuals who have contracted COVID-19 are at a higher risk of developing cardiovascular conditions like irregular heartbeat, stroke, and heart failure.

The connection between COVID-19 and cardiovascular disease has been observed, highlighting the potential long-term impact of the virus on cardiovascular health. This correlation emphasizes the importance of addressing and monitoring the cardiovascular health of individuals who have had COVID-19, as well as the need for continued research and advancements in cardiovascular diagnostics and treatments to mitigate the potential consequences of the disease. Overall, the cardiovascular diagnostic market is likely to expand in the next years, offering a cost-effective and simple option for patients suffering from CVDs.

Key Takeaways from this Global Cardiovascular Diagnostics Industry:

  • Electrocardiogram (ECG) systems hold a significant market share of 43.4% in the global cardiovascular diagnostics market in 2022 due to the prominence of ECG systems globally.
  • Hospitals take away the larger share among all end users due to the availability of most diagnostic products and equipment in the hospitals. The segment held around 30.5% value share in 2022.
  • The North American region accounts for the dominant market share at 37.4%, with a market value of US$ 2.1 Billion in 2022 owed to the strong market presence of key players in North America contributing to the overall advancement and expansion of the cardiovascular diagnostics market.

“The increasing global prevalence of the cardiovascular disease has led to a growing demand for CVD diagnostics in recent years, this presents a favourable opportunity for entry into the cardiovascular disease diagnostic market,” – says an analyst at Future Market Insights (FMI).

Ask Us Your Questions About This Report
https://www.futuremarketinsights.com/ask-question/rep-gb-17465

Global Cardiovascular Diagnostics Industry Competition:

The cardiovascular diagnostic industry is extremely competitive, with GE Healthcare and Abbott Laboratories among the leading participants. To achieve a greater market share, these firms are continually reinventing their goods and marketing techniques, with an emphasis on price, convenience, and efficacy.

  • In February 2023, GE HealthCare aims to revolutionize ultrasounds by making them accessible worldwide, as demonstrated by their recent acquisition of Caption Health, an AI software company specializing in cardiac imaging.
  • In September 2022, SRL Diagnostics introduces ‘Heart Assure’, a specialized blood test using high-sensitivity Troponin I to accurately predict the risk of cardiac events.

What Does This Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the cardiovascular diagnostic market in its latest study, presenting a historical demand assessment of 2017– 2022 and projections for 2023 – 2033. The cardiovascular diagnostic market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the Electrocardiogram (EEG) systems (resting ECG systems, cardiopulmonary stress testing systems), Holter monitoring devices, Event monitoring devices (Implantable Loop Recorder (ILR), others) and point of care testing (Analyzers lipoprotein test kits, angiotensin test kits, fibrinogen test kits, serum uric acid test kits, high-sensitivity CRP (hs-CRP) kit), across 7 key regions of the world.

Global Cardiovascular Diagnostics Industry Key Players:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Schiller, Koninklijke Philips N.V.
  • GE Healthcare and Wayra
  • Siemens Healthcare
  • Lepu Medical
  • Midmark Corp
  • Roche Ltd
  • Randox Laboratories Ltd.
  • Robotnik India
  • Diasorin
  • Elabscience Biotechnology

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/17465

Key Segmentation from the Global Cardiovascular Diagnostics Industry:

By Product:

  • Electrocardiogram (ECG) system
  • Resting ECG Systems
  • Cardiopulmonary Stress Testing Systems
  • Holter Monitoring Devices
  • Event Monitoring Devices
  • Implantable Loop Recorder (ILR)
  • Others

By Point-of-Care Testing:

  • Analyzers
  • Lipoprotein Test Kits
  • Angiotensin Test Kits
  • Fibrinogen Test Kits
  • Serum Uric Acid Test Kits
  • High-Sensitivity CRP (hs-CRP) Kits

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Cardiac Catheterization Labs
  • Diagnostic Imaging Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

USA Knotless Surgical Sutures Industry Poised for Robust 3.6% CAGR, Eyes Impressive US$258.7 Million Valuation by 2033 | FMI

Future Market Insights (FMI), a leading market research firm, unveils groundbreaking insights into the USA Knotless Surgical Sutures Industry, forecasting a remarkable compound annual growth rate (CAGR) of 3.6% during the forecast period. The market is anticipated to witness a substantial surge, escalating from its 2023 valuation of US$181.0 million to an impressive US$258.7 million by 2033.

In a dynamic landscape where innovation is paramount, leading companies are channeling their efforts into extensive research, aiming to unveil new and improved versions of knotless surgical sutures. These advancements include the incorporation of synthetic materials to enhance tissue-holding properties, the introduction of antibacterial or Triclosan-coated polyglactin 910 sutures, the development of barbed sutures, utilization of braiding technologies, and the creation of absorbable sutures from fibers sourced from animal intestines or artificially engineered polymers.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17299

In July 2022, Dolphin Sutures launched a range of antibacterial sutures to reduce surgical site infection prevalence.

The rise in disposable income is expected to be another important factor driving the growth of the Knotless Surgical Sutures market. Increasing disposable income enables an excellent growth opportunity for surgical suture manufacturers to connect with potential end users.

Rising disposable income can fuel investments in research and development within the healthcare industry. Higher disposable income enables companies to invest in innovation, improving the quality and effectiveness of Knotless Surgical Sutures.

These factors are fueling the expansion of the USA Knotless Surgical Sutures market.

Key Takeaways from USA Knotless Surgical Sutures Industry Study

  • Absorbable surgical sutures are the leading products and held about 61.0% market share in 2022. Absorbable sutures are commonly used for internal tissues that heal relatively quickly or in areas that are difficult to access for suture removal.
  • By raw material, polyglactin absorbable surgical sutures are the predominant type and are significantly linked to high biocompatibility, versatility and convenient handling characteristics, and held about 22.4% market share in 2022.
  • The synthetic source segment held the dominant market share of 51.3%, as it eliminated the need for tying knots, which can significantly reduce the time required for suturing.
  • Cardiovascular procedures held the dominant market share of 32.2%, as the number of cardiovascular procedures are rising in the USA
  • Hospital laboratories segment by end user accounted for a revenue share of 34.9% in the USA market at the end of 2022. Hospital laboratories are important in evaluating the performance and characteristics of various sutures which assess factors such as suture strength, biocompatibility, and tissue response
  • By state, Northeast is leading in the USA knotless sutures market and is expected to continue to do so with a projected CAGR rate of 5.0% during the forecasted years.

“Improving Patient-Centered Outcomes, Advancements in Surgical Suture Materials and Increasing Demand for Absorbable Sutures are the Key Drivers of the USA Knotless Surgical Sutures Market,” says an analyst of Future Market Insights.

USA Knotless Surgical Sutures Industry Competition

Key companies in the USA Knotless Surgical Sutures market are pursuing market expansion by utilizing growth methods like collaborations, agreements, and acquisitions. These businesses place a high priority on boosting sales efforts and using new technologies to create cutting-edge products.

  • In May 2022, Medtronic plc announced that it had successfully acquired Intersect ENT, adding cutting-edge products which are being used to treat nasal polyps and into the sinus operations to enhance post-operative outcomes and to the company’s comprehensive ENT portfolio.
  • Two new contracts for Ethicon sutures, endo-mechanicals, and trocars were announced in March 2018 by Intalere, a leader in the healthcare sector in terms of achieving optimal cost, quality, and clinical outcomes.

USA Knotless Surgical Sutures Industry Key Companies Profiled

  • Medtronic
  • Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson (Ethicon)
  • CONMED Corporation
  • Corza Medical
  • CP Medical
  • DemeTECH Corporation
  • Sutumed
  • DSI Dental Solution
  • Golnit Sutures
  • Vital Sutures
  • Atramat

USA Knotless Surgical Sutures Industry
https://www.futuremarketinsights.com/checkout/17299

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the USA Knotless Surgical Sutures market in its latest study, presenting a historical demand assessment of 2015 to 2022 and projections for 2023 to 2033. The USA Knotless Surgical Sutures market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Key Segments Covered in USA Knotless Surgical Sutures Industry Research

By Product:

  • Absorbable Surgical Sutures
  • Non- Absorbable Surgical Sutures

By Raw Material:

  • Polyglycolic Acid Absorbable Surgical Suture
  • Polyglactin Absorbable Surgical Sutures
  • Catgut Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polyester Non-Absorbable Surgical Sutures
  • Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures

By Source:

  • Natural
  • Synthetic
    • Monofilament
    • Braided
  • Coated
  • Uncoated

By Application:

  • Cardiovascular Procedures
  • General Surgery Procedures
  • Ophthalmic Procedures
  • Orthopedic Procedures
  • Dental Procedures
  • Gastroenterology Procedures
  • Gynecology Procedures
  • Plastic Surgery Procedures
  • Veterinary Procedures

By End User:

  • Hospital Laboratories
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Veterinary Hospitals
  • Veterinary Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Veterinary Sutures Industry on Track to Achieve US$482.10 Million by 2033, Fueled by 3.8% CAGR | FMI

Future Market Insights (FMI), a leading market research firm, has unveiled its latest industry analysis, indicating a noteworthy growth trajectory for the Global Veterinary Sutures Industry. As of 2022, the market valuation stands at approximately US$ 323.00 Million, with a forecasted Compound Annual Growth Rate (CAGR) of nearly 3.8% anticipated over the coming years. FMI projects the market to achieve an estimated valuation of US$ 482.10 Million by the year 2033.

Veterinary sutures play a pivotal role in various surgical procedures, serving to close wounds and incisions. The primary objective of sutures is to facilitate tissue healing by securely holding them together. With an increasing emphasis on animal welfare and the adoption of best practices in veterinary care, the demand for high-quality veterinary sutures has witnessed a significant upswing.

Pet owners, in particular, are becoming more discerning about the healthcare provided to their beloved animals. This growing awareness has translated into a willingness to invest in advanced surgical procedures that can enhance their pets’ quality of life. Simultaneously, veterinary organizations worldwide are prioritizing animal welfare, actively promoting the incorporation of best practices in veterinary care.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17270

Hence, the increasing focus on animal welfare is indeed one of the factors that are driving the growth in sales of veterinary sutures. The use of sutures is an essential part of surgical procedures for animals and is crucial for promoting faster healing and minimizing post-operative complications. By using high-quality veterinary sutures, veterinarians can ensure that animals recover from surgery as quickly and safely as possible, which is a key component of animal welfare.

As a result, the demand for high-quality veterinary sutures is increasing, as pet owners and veterinarians seek to ensure the best possible outcomes for animals undergoing surgery. Suture manufacturers are responding to this demand by developing new and improved sutures that are specifically designed for veterinary use, and by investing in research and development to advance the field of veterinary surgery.

Overall, these factors are contributing to the growth of the Global Veterinary Sutures Industry, and are expected to continue to drive demand for veterinary sutures in the coming years.

Key Takeaways from Global Veterinary Sutures Industry Study

  • Absorbable sutures are the leading segment among suture types, and held about 7 market share in 2022, due to their reduced cost and inconvenience, fewer tissue reactions, and decreased risk of long-term complications.
  • By raw material type, polyglactin absorbable surgical sutures held about 3% of the market share in 2022, polyglactin absorbable surgical sutures is a popular choice of veterinary surgeons in various surgical procedures due to their excellent handling characteristics, low inflammatory response, availability of different sizes and lengths.
  • By End User, the veterinary hospitals dominated the global veterinary sutures market withholding the total market share of about 4% by the end of 2022, owing to their larger staff and inventory of surgical supplies.
  • By region, Europe is leading in the global veterinary suture market and is expected to continue to do so with a projected CAGR rate of 9 during the forecasted years.

Global Veterinary Sutures Industry Key Companies Profiled

  • Braun
  • Ethicon
  • Medtronic Plc
  • Betatech Medical
  • Changzhou Zener Medtec
  • Gamastech
  • Génia
  • KATSAN Medical Devices
  • RWD Life Science
  • Somni Scientific
  • CP Medical
  • Vetersut
  • Vitrex Medical
  • AIP Medical SA
  • Oasis
  • GPC Medical Ltd
  • AdvaCare Pharma
  • Cortis

Tap into Comprehensive Segmented Information – Purchase Today! @
https://www.futuremarketinsights.com/checkout/17270

Global Veterinary Sutures Industry Competition

Leading players are adopting key strategies like expanding sales by launching new products and collaborations for the creation of novel products.

  • In March 2023, Animus Surgical launched a new transparent, non-toxic and biodegradable hydrogel wound sealant to replace bandages, which protects the suture lines.
  • In September 2022, Johnson & Johnson announced the news that they are establishing two independent, market-leading companies with the announcement of Kenvue. Kenvue is a new consumer healthcare company.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the veterinary sutures market in its latest study, presenting a historical demand assessment of 2015 – 2022 and projections for 2023 – 2033. The global veterinary sutures treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on suture type– (absorbable sutures, non-absorbable sutures), raw material type (catgut absorbable surgical sutures, polyglactin absorbable surgical sutures, poliglecaprone absorbable surgical sutures, polydioxanone absorbable surgical sutures, polyglycolic acid absorbable surgical sutures, silk non-absorbable surgical sutures, nylon (poylamide) non-absorbable surgical sutures, polypropylene non-absorbable surgical sutures, stainless steel non-absorbable surgical sutures), end user — (veterinary hospitals, veterinary clinics, academic & research institutes), across seven regions of the world.

Key Segments Covered in Global Veterinary Sutures Industry Research

By Suture Type:

  • Absorbable Sutures
  • Non-Absorbable Sutures

By Raw Material:

  • Catgut Absorbable Surgical Sutures
  • Polyglactin Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polyglycolic Acid Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures
  • Others

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Refurbished Dental Equipment Industry Envisioning a US$ 1.8 Billion Valuation by 2033 at 8.7% CAGR | FMI

Future Market Insights, a leading market research firm, has released its latest industry analysis, unveiling a promising outlook for the Global Refurbished Dental Equipment Industry. In 2022, the industry witnessed a valuation of approximately US$ 741.9 Million, and projections suggest an impressive Compound Annual Growth Rate (CAGR) of close to 8.7% over the forecast period.

Refurbished dental equipment includes instruments, devices, and tools that have undergone meticulous restoration or repair to bring them back to a usable and high-quality condition. Typically sourced from dental offices, clinics, or laboratories where they were previously in use, these supplies are no longer needed or have been replaced.

The perception of refurbished dental equipment has changed over time, with increased awareness and acceptance of its benefits. Dental professionals are becoming more knowledgeable about the refurbishment process and the quality assurance measures taken by reputable refurbishment companies. As a result, there is a growing acceptance of refurbished equipment as a viable alternative to new purchases.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-17266

The rising cost of healthcare and the increasing financial pressures on dental practices have led to a growing demand for cost-effective solutions. Refurbished dental equipment provides an opportunity for practices to reduce their upfront investment while still obtaining reliable equipment. This trend is likely to continue as dental professionals seek ways to optimize their budgets without compromising on quality.

Cost savings is a significant driver for the adoption of refurbished dental equipment. Dental practices, especially small and independent ones, are often looking for ways to reduce their expenses. Refurbished equipment offers a cost-effective alternative to purchasing new equipment, allowing dental professionals to acquire necessary instruments and machinery at a lower price point.

The market for refurbished dental equipment is developing because access to affordable dental equipment can be limited, and refurbished options provide a more accessible solution. The demand for refurbished equipment is growing as dental practices strive to improve their infrastructure and expand their services.

Overall, these factors are contributing to the growth of the Global Refurbished Dental Equipment Industry, and are expected to continue to drive demand for effective and customized products in the coming years.

Global Refurbished Dental Equipment Industry Key Takeaways:

  • Specialized dental equipment is the leading segment application among dentists and healthcare professionals, and held about 65.2% market share in 2022, specialized dental equipment such as intraoral cameras, dental lasers & 3D imaging systems allows the dentist to directly visualize inside the mouth, and to take images for better examination or surgeries.
  • By end user, the hospitals dominated the global refurbished dental equipment market withholding the total market share of about 42.1% by the end of 2022, owing to the convenience and ease of accessibility to new technologically advanced refurbished equipment.
  • By region, North America is leading in the global refurbished dental equipment market and is expected to gain a market share of 36.3% in 2022.

“High Costs associated with Dental Equipment and Rising Prevalence of Dental Conditions is Prompting Dental Practitioners to Opt for Refurbished Equipment, thereby fuelling the Global Market,” – says an analyst at Future Market Insights (FMI).

Methodology Details Just a Click Away! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-17266

Global Refurbished Dental Equipment Industry Competition:

Partnerships, purchases, mergers, and various other corporate growth methods are used by major market participants to build their businesses. Major players concentrate on strategies including boosting sales and utilizing innovative technologies for the creation of novel products.

  • Atlantic Street Capital partnered with Renew Digital in August 2021. Renew Digital is a well-known provider of dental imaging equipment as well as technical support and service for dental practices all over the world.
  • In March 2023, Planmeca is excited to showcase several Romexis improvements with new AI-based tools which will help optimize the dentist’s daily tasks and make it faster and more efficient to work with patient images & treatment at the International Dental Show 2023.

Global Refurbished Dental Equipment Industry Key Players:

  • American Dental Refurbishment
  • Atlas Resell Management
  • A & K Dental Equipment
  • Capital Dental Equipment
  • Collin’s Dental Equipment, Inc.
  • Independent Dental Inc.
  • Pre-Owned Dental Inc.
  • SPS Dental
  • Renew Digital LLC
  • DCI Dental Equipment

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/17266

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the refurbished dental equipment market in its latest study, presenting a historical demand assessment of 2018 to 2022 and projections for 2023 to 2033. The global refurbished dental equipment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on product – {specialized dental equipment (intraoral cameras, chairside CAD/CAM systems, 3D imaging systems, surgical microscopes, dental lasers, endodontic equipment, cone beam computed tomography (CBCT) systems, others), essential dental equipment’s ( dental patient chairs, delivery systems, dental operatory lights, X-ray imaging equipment, sterilization equipment, handpiece, utility equipment, others)} end user- (hospitals, independent dental clinics, group dental practices, ambulatory surgical centers) & across seven regions of the world.

Global Refurbished Dental Equipment Industry Key Segments Covered:

By Product:

  • Specialized Dental Equipment
    • Intraoral Cameras
    • Chairside CAD/CAM Systems
    • 3D Imaging Systems
    • Surgical Microscopes
    • Dental Lasers
    • Endodontic Equipment
    • Cone Beam Computed Tomography (CBCT) Systems
    • Others
  • Essential Dental Equipment
    • Dental Patient Chairs
    • Delivery Systems
    • Dental Operatory Lights
    • X-ray Imaging Equipment
    • Sterilization Equipment
    • Handpieces
    • Utility Equipment
    • Others

By End User:

  • Hospitals
  • Independent Dental Clinics
  • Group Dental Practices
  • Ambulatory Surgical Centers

 About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Mastectomy Reconstruction Implants Industry Surges Ahead with 8.4% CAGR, Envisioning US$4.69 Billion Milestone by 2033 | FMI Insights

The Global Mastectomy Reconstruction Implants Industry is currently valued at US$2.09 Billion and is poised to witness an impressive surge, projected to reach a staggering US$4.69 Billion by 2033, boasting a commendable CAGR of 8.4% between 2023 and 2033.

In a world where cosmetic surgeries are on the rise, the forecasted period indicates an unstoppable growth trajectory for the global mastectomy reconstruction implants market. Addressing the evolving needs of patients post-breast augmentation and reconstruction, Evonik and BellaSeno joined forces in November 2019 to introduce advanced 3D-printed breast implant technology. This collaboration aims to enhance the quality of life for individuals undergoing these transformative procedures.

The partnership between Evonik and BellaSeno marks a significant step forward in the field of mastectomy reconstruction, with a commitment to leveraging cutting-edge technology for the betterment of patients. The 3D-printed breast implant technology is designed not only to meet the aesthetic demands of patients but also to provide a solution that contributes to their overall well-being post-surgery.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17249

At the same time, the increasing risk of complications in breast implant surgery is expected to restrain the mastectomy reconstruction implants market as women may ultimately prefer removing breast implants. The American Society of Plastic Surgeons (ASPS) states that the overall complication rate related to breast reconstruction surgery is close to 10% (the most common complication being infection).

Future Market Insights has etched these facts with future prospects in its latest market study entitled ‘Mastectomy Reconstruction Implants Market’. It has a team of analysts and consultants to execute using a bottom-up approach across macros and micros.

“With technologically advanced breast implants being readily available, the global mastectomy reconstruction implants market is likely to grow on a good note in the forecast period”, says an analyst from Future Market Insights.

Key Takeaways from the Global Mastectomy Reconstruction Implants Industry

  • North America holds more than 40% of the market share. This could be attributed to the growing number of women contracting breast cancer. This is evident from the fact that the Canadian Cancer Society states that nearly 78 Canadian women contract breast cancer every single day; and also that ~15 women succumb to breast cancer daily. This comes to ~25% of novel cases of cancer on the whole.
  • The Asia-Pacific is expected to witness maximum growth in the mastectomy reconstruction implants market going forward due to growing awareness about the need for early diagnosis of breast cancer and treatment thereafter. NCBI has stated that ~70,400 fatalities with ~303,600 new cases have been detected all over China of late. It has also been observed that more than 70% of women opted for breast reconstruction post-mastectomy.
  • Europe is led by Germany and the future scenario is expected to remain the same even going forward. This could be attributed to advancements in surgical technology followed by increase in medical tourism. In other words, several women travel to Germany to undergo breast reconstruction surgery.
  • LATAM is expected to pick up pace in this regard shortly. The National Cancer Institute (INCA) has stated that breast cancer happens to be the second-most common form of cancer in Brazil.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/17249

Competitive Implants

  • Allergan, Inc., in 2020, did receive approval from the US FDA for its Natrelle Inspira SoftTouch breast implants. The basic purpose is to provide a softer feel along with a natural look for the ones going through breast reconstruction surgery.
  • GC Aesthetics plc, in 2020, did receive approval from the US FDA with regards to NaturaCel breast implants. They are designed to enable comfort to women undergoing this surgery.
  • POLYTECH Health & Aesthetics GmbH, in May 2020, announced an expansion of the production facility.
  • Sientra, in 2020, received approval from the US FDA for OPUS-branded breast implant products.
  • The US FDA, in 2022, approved a new-fangled ‘MENTOR Memory Gel boost breast implant’ from Mentor Worldwide LLC (Johnson & Johnson).
  • RealSelf, in May 2019, collaborated with the American Society for Aesthetic Plastic Surgery to launch an educational program to spread awareness about breast implants.

What does the Report implant?

  • The research study is based on product (two-stage implant reconstruction (matrix (ADM)) (prepectoral breast reconstruction surgery and sub-pectoral breast reconstruction surgery) and direct-to-implant reconstruction), and by end-user (hospitals, cosmetology clinics, ambulatory surgical centers, and medical spas).
  • With growing incidences of breast cancer coupled with demand for cosmetic surgeries, the global mastectomy reconstruction implants market is bound to grow impeccably in the forecast period.

Key Segments Covered in Global Mastectomy Reconstruction Implants Industry Research

By Product:

  • Two-Stage Implant Reconstruction (matrix (ADM))
    • Prepectoral Breast Reconstruction Surgery
    • Sub-pectoral Breast Reconstruction Surgery
  • Direct-to-Implant Reconstruction

By End User:

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgical Centers
  • Medical Spas

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Esophageal Implant Industry Forecasted to Surge to US$ 280.2 Million by 2033, Backed by a Strong 6.7% Compound Annual Growth Rate | Future Market Insights, Inc.

Future Market Insights (FMI), a leading market intelligence and consulting firm, forecasts a substantial growth trajectory for the Global Esophageal Implant Industry. According to their latest report, the market is projected to expand from US$ 147.0 million in 2023 to a noteworthy US$ 280.2 million by 2033, demonstrating a remarkable 6.7% Compound Annual Growth Rate (CAGR) over the next decade.

Several key factors are anticipated to fuel this significant market expansion. The rising prevalence of esophageal illnesses and the increasing preference for minimally invasive procedures are identified as primary drivers. As healthcare trends continue to evolve, the demand for advanced solutions like esophageal implants is expected to witness a substantial surge.

Technological advancements and continuous product innovation will also play a pivotal role in driving the adoption of esophageal implants. The market is likely to benefit from improved attributes such as enhanced biocompatibility, increased durability, ease of insertion, and enhanced patient comfort. These factors are poised to not only boost market share but also drive substantial sales growth.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-17242

Compliance with regulatory requirements and regulatory approvals are required for the commercialization and selling of esophageal implants. Companies that have gotten all of the relevant certifications and approvals have a competitive advantage and better sales.

Reimbursement policies and coverage for esophageal implants have an impact on sales since they affect patients’ access to and affordability of these devices. Favorable reimbursement regulations can boost esophageal implant acceptance and sales.

Because of variances in healthcare infrastructure, disease incidence, economic variables, and cultural factors, demand for esophageal implants varies among areas and countries. Companies may need to adjust their sales strategy to target various regional areas.

Global Esophageal Implant Industry Key Takeaways:

  • Global sales of esophageal implants are expected to surge at 7% CAGR through 2033.
  • Based on the product, the esophageal stents segment is forecast to progress at 0% CAGR from 2023 to 2033.
  • By application, the gastroesophageal reflux disease (GERD) segment is poised to exhibit 4% CAGR through 2033.
  • By end-use, the hospitals segment is anticipated to expand at a CAGR of 1% over the forecast duration.
  • The United States esophageal implant market value is likely to reach US$ 105.2 million by 2033.
  • The United Kingdom’s esophageal implant industry is estimated to reach a valuation of US$ 14.11 million by 2033.
  • Esophageal implant demand in China is expected to increase at 6% CAGR through 2033.
  • Japan’s market is predicted to reach a valuation of US$ 4.4 million by 2033.
  • South Korea’s esophageal implant industry is poised to exhibit a 9% CAGR during the forecast period.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-17242

“Rising prevalence of esophageal disorders globally will create high demand for esophageal implants during the assessment period. To gain profits, manufacturers should focus on markets with favorable regulatory environments and operational guidelines.” – says a lead analyst at Future Market Insights (FMI)

Who is winning?

Leading manufacturers of esophageal implants include Boston Scientific, Medtronic, Cook Medical, Taewoong Medical., Micro-Tech (Nanjing) Co., Ltd., Ella-CS, M.I. Tech, Merit Medical, Xlumena Inc., Olympus Corporation, Johnson & Johnson, Apollo Endosurgery, Inc., EndoStim, NDO Surgical, Inc, Mederi Therapeutics, Becton Dickenson & Company, and Baxter International (Synovis Surgical Innovations) among other companies.

These key players are increasingly spending money on research and development activities to develop new products with better features. To fulfill shifting customer needs, they are also focusing on expanding their product line and bolstering their distribution networks.

Tactical alliances and connections with other firms are progressively popular in the sector, permitting participants to utilize one another’s strengths and broaden their influence in the marketplace.

Leading firms also adopt strategies such as mergers, partnerships, acquisitions, and collaborations to strengthen their position in the market and get access to new markets.

Global Esophageal Implant Industry Recent developments:

  • In 2020, Olympus started the commercial launch of the HANAROSTENT Esophagus TTS Stent.

More Insights Available:

Future Market Insights (FMI), in its new offering, presents an unbiased analysis of the Global Esophageal Implant Industry presenting historical data (2017 to 2022) and forecast statistics for the period from 2023 to 2033.

The study reveals future market projections based on the product (esophageal stents, magnetic sphincter augmentation (MSA) devices, injectable bulking agents, and artificial esophageal valves), application (gastroesophageal reflux disease (GERD), esophageal strictures, esophageal fistulas, esophageal defects, and weakened esophageal sphincters), and end-user (hospitals, ambulatory surgical centers, specialty clinics, academic & research institutions, and weakened esophageal sphincters) across various regions.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-17242

Global Esophageal Implant Industry Segmentation:

By Product:

  • Esophageal Stents
    • Self-Expandable Metal Stents (SEMS)
    • Polymer Stents
    • Biodegradable Stents
    • Hybrid Stents
  • Magnetic Sphincter Augmentation (MSA) Devices
  • Injectable Bulking Agents
  • Artificial Esophageal Valves
    • Endoscopic Esophageal Valves
    • Prosthetic Esophageal Valves

By Application:

  • Gastroesophageal Reflux Disease (GERD)
  • Esophageal Strictures
  • Esophageal Fistulas
  • Esophageal Defects
  • Weakened Esophageal Sphincters

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic & Research Institutions
  • Weakened Esophageal Sphincters

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Steam Trap Market to Soar to US$ 8 Billion by 2033, Driven by Automation and Regulatory Compliance

The steam trap Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the steam trap market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for steam trap. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The global steam trap market is on a remarkable growth path, with projections indicating that it will expand substantially. Starting at a significant US$ 4.2 billion in 2023, it is expected to reach an impressive US$ 8 billion by 2033. This remarkable ascent is primarily driven by an expected Compound Annual Growth Rate (CAGR) of 6.8% over the entire forecast period.

Driving Factors

Automation’s Ascendancy: The prevailing surge in the steam trap market is unequivocally fueled by the rapid proliferation of automation, particularly within the oil and gas industry. As enterprises worldwide gravitate towards streamlined, efficient operations, the indispensability of steam traps becomes increasingly apparent. Automation optimizes processes, reduces human error, and ultimately elevates overall productivity, positioning steam traps as an essential cog in the wheel of industrial progress.

Regulatory Imperatives: Regulatory authorities are leaving no stone unturned in their quest to augment industrial efficiency and curtail operational costs. Stringent requirements, laden with the imperative to embrace energy-saving practices, have set the stage for the ascendance of steam traps. Compliance with these mandates is non-negotiable, propelling the demand for steam traps as a cornerstone in achieving both environmental and financial sustainability.

Stay at the Forefront of Industry Trends: Request a Sample to Gain a Comprehensive Market Overview and Discover Lucrative Growth Opportunities
https://www.futuremarketinsights.com/reports/sample/rep-gb-17449

Demand for Durability and Efficiency: In an era where durability and efficiency are at a premium, the market is witnessing a surge in demand for robust, lightweight steam traps endowed with extended operational lifespans. This confluence of factors has catapulted steam traps into the forefront of industrial utilities, offering a solution that seamlessly combines reliability, longevity, and efficiency.

Restraints

While the prospects for the global steam trap market are undoubtedly promising, there exist notable constraints that warrant consideration:

Capital Intensity: The adoption of steam traps, while crucial, necessitates initial capital investment. This outlay, though offset by long-term cost savings, may deter some smaller enterprises from immediate adoption. It’s imperative for businesses to recognize the long-term value proposition of steam traps beyond the initial financial commitment.

Complexity of Integration: Integrating steam traps into existing industrial systems can be a complex undertaking, requiring meticulous planning and execution. The challenge lies in harmonizing these intricate devices seamlessly with established processes. However, it’s important to note that the rewards of this integration far outweigh the initial complexity.

In summary, the global steam trap market’s remarkable trajectory is driven by the forces of automation, regulatory compliance, and an insatiable appetite for efficient, durable solutions. While capital intensity and integration complexities pose challenges, they are far outweighed by the substantial benefits in terms of efficiency, cost savings, and environmental responsibility. The global steam trap market is primed for exponential growth as it continues to stand as a paragon of industrial excellence.

Competitive Terrain:

Within any given market, the presence of multiple companies vying to provide identical products or services is a common occurrence. In the realm of steam trap manufacturers and suppliers, a dynamic landscape of competition unfolds, with each player striving to offer solutions that precisely cater to the diverse demands of various industries.

Key drivers in the steam trap market competition include product quality, performance excellence, unwavering dependability, energy efficiency, cost-effectiveness, and a commitment to superior customer service. Companies carve their niche in this highly competitive arena by introducing unique features, advanced technologies, and tailored solutions meticulously crafted to align with the specific requirements of their clientele. As a strategic edge, some enterprises may extend supplementary services such as maintenance, comprehensive training programs, and technical support, all aimed at securing a distinctive competitive advantage.

Get in Touch with our Sales Team for Further Assistance in Acquiring this Report https://www.futuremarketinsights.com/checkout/17449

Pivotal Steam Trap Manufacturers

  • Armstrong International Inc.
  • Miyawaki Inc.
  • Emerson Electric Co.
  • Pentair
  • Spirax-Sarco Engineering plc
  • CIRCOR International, Inc.
  • The Weir Group
  • Flowserve
  • Hawa Engineers Ltd.
  • Bestobell Steam Traps
  • Thermal Energy International Inc.

Key Segments

By Product:

  • Thermodynamic
  • Mechanical
  • Thermostatic

By Application:

  • Drip Application
  • Process Application
  • Tracing Application

By Material:

  • Steel
  • Iron

By End User:

  • Oil & Gas
  • Power Industry
  • Pharmaceuticals
  • Food & Beverage
  • Pulp & Paper
  • General Industry
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Tailored Expertise: Advancing Opportunities in the Steam Trap Market https://www.futuremarketinsights.com/customization-available/rep-gb-17449

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com